Physician profile
Madeline Jo Gresham
NPI 1124748009
$2,300.38
in general payments reported to CMS, 2019-2025
12 companies · $406 in 2025
The $406 reported for 2025 was more than what 82% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $209 · 2024: $1,685 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,262 · Food and Beverage: $968 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,262.04 |
| Food and Beverage | $968.35 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,598.36 | 2024-2025 | Solyx Sis System |
| Astellas Pharma US INC | $196.22 | 2023-2025 | Veozah |
| Amgen INC. | $148.97 | 2025 | Evenity, Prolia |
| Organon LLC | $102.39 | 2023-2025 | Nexplanon |
| Axonics, INC. | $82.41 | 2024 | Axonics |
| Bayer Healthcare Pharmaceuticals INC. | $46.58 | 2025 | |
| Biogen, INC. | $29.13 | 2025 | Zurzuvae |
| Vertex Pharmaceuticals Incorporated | $22.71 | 2025 | |
| Agile Therapeutics, INC. | $22.60 | 2023 | Twirla |
| Exeltis, USA INC. | $18.70 | 2025 | Slynd |
| Novo Nordisk INC | $16.26 | 2025 | Wegovy |
| Hologic Sales and Service, LLC | $16.05 | 2025 | Myosure Tissue Removal Device |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madeline Gresham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.